Communiqué de presse
Nh TherAguiX society has been created in December 2015 in order to develop AGuIX nanoparticles for the clinic. The society proposes new therapeutic solutions against cancer. These solutions are based on the AGuIX technology developed since more than 10 years by FENNEC team of ILM, Nano-H society and many other partners. It is based on the use of hybrid nanodrugs that accumulate passively in the tumors and are then detected by MRI before their activation by radiotherapy.
Contact :
29/01/2016